Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
27.77
Jul 15 • 12:30PM ET Dollar change+2.28 Percentage change(8.94%)
Index
RUT
Market Cap
2.39B
Enterprise Value
2.26B
Income
-111.83M
Sales
191.42M
Book/sh
3.32
Cash/sh
1.84
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
843
IPO
Aug 08, 2025
P/E
-
Forward P/E
-
PEG
-
P/S
12.51
P/B
8.37
P/C
15.13
P/FCF
-
EV/EBITDA
-
EV/Sales
11.82
Quick Ratio
5.36
Current Ratio
5.36
Debt/Eq
0.09
LT Debt/Eq
0.07
Option/Short
Yes / Yes
EPS (ttm)
-1.33
EPS next Y
-0.26
EPS next Q
-0.13
EPS this Y
69.66%
EPS next Y
46.22%
EPS next 5Y
-
EPS past 3/5Y
5.20% -
Sales past 3/5Y
42.10% -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
19.77%
Sales Q/Q
41.34%
Insider Own
26.07%
Insider Trans
-16.35%
Inst Own
67.61%
Inst Trans
17.53%
ROA
-42.32%
ROE
-135.31%
ROIC
-36.58%
Gross Margin
78.06%
Oper. Margin
-35.83%
Profit Margin
-58.42%
SMA20
-8.90%
SMA50
-7.26%
SMA200
-6.71%
Trades
Shs Outstand
86.11M
Shs Float
63.75M
52W High
41.22 -32.63%
52W Low
20.13 37.95%
Volatility
6.57% 7.46%
ATR (14)
2.12
RSI (14)
44.76
Beta
-
Rel Volume
0.63
Avg Volume
1.50M
Volume
461,346
Perf Week
6.20%
Perf Month
-16.46%
Perf Quarter
-4.41%
Perf Half Y
-12.65%
Perf YTD
-4.73%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
25.49
Price
27.77
Change
8.94%
Date Action Analyst Rating Change Price Target Change
May-04-26Initiated William Blair Outperform
Jan-28-26Initiated Wells Fargo Overweight $38
Sep-02-25Initiated Stifel Buy $35
Sep-02-25Initiated Piper Sandler Overweight $38
Sep-02-25Initiated Morgan Stanley Equal-Weight $35
Sep-02-25Initiated JP Morgan Overweight $36
Sep-02-25Initiated Canaccord Genuity Buy $35
Jul-09-26 08:00AM
Jun-16-26 09:11AM
May-15-26 01:02AM
May-14-26 04:28PM
04:01PM
09:16AM Loading…
May-13-26 09:16AM
Apr-23-26 04:05PM
Apr-13-26 08:30AM
Mar-27-26 09:30AM
Mar-18-26 11:00PM
04:22PM
04:01PM
Mar-17-26 09:18AM
Mar-16-26 08:00AM
Feb-25-26 01:26AM
04:05PM Loading…
Feb-18-26 04:05PM
Feb-13-26 04:21PM
Feb-12-26 08:00AM
Jan-29-26 09:41AM
Jan-28-26 09:39AM
Jan-06-26 08:00AM
Jan-05-26 04:05PM
Dec-23-25 11:53PM
Dec-18-25 07:42PM
04:05PM
Dec-12-25 09:49AM
Dec-11-25 03:10AM
Nov-19-25 04:33PM
Nov-12-25 04:22PM
04:01PM
01:30PM Loading…
Nov-09-25 01:30PM
Nov-04-25 07:06AM
Nov-03-25 08:00AM
Oct-23-25 04:05PM
Oct-22-25 08:00AM
Sep-29-25 08:07AM
Sep-23-25 06:55PM
Sep-22-25 04:05PM
Sep-19-25 05:28PM
Sep-11-25 01:00AM
Sep-06-25 06:35AM
Sep-04-25 10:20AM
Sep-03-25 04:54PM
04:54PM
09:16AM
Sep-02-25 09:45AM
Aug-27-25 04:24PM
Aug-18-25 01:16PM
Aug-11-25 04:30PM
Aug-09-25 09:53AM
Aug-08-25 01:40PM
Jul-22-25 06:28PM
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.
PresidentMr. John C.M. Farquhar
Chief Financial OfficerMr. Vikram Verghese C.F.A.
M.D.Dr. Campbell D.K. Rogers FACC
Co-FounderDr. John Henry Stevens M.D.
Senior Vice President of OperationsMs. Kathleen Carey
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rogers CampbellOfficerJul 15 '26Proposed Sale25.729,219237,113Jul 15 10:05 AM
Farquhar John C.M.Chief Executive OfficerJul 10 '26Sale27.7522,562626,096435,373Jul 13 08:25 PM
WELDON WILLIAM CDirectorJul 08 '26Option Exercise8.3351,369427,904243,931Jul 10 05:50 PM
Farquhar John C.M.OfficerJul 10 '26Proposed Sale27.7522,562626,096Jul 10 09:43 AM
Farquhar John C.M.Chief Executive OfficerJun 24 '26Sale35.0038,9001,361,500457,935Jun 26 06:08 PM
Farquhar John C.M.OfficerJun 24 '26Proposed Sale35.0038,9001,361,500Jun 24 10:38 AM
Rogers CampbellChief Medical OfficerJun 15 '26Option Exercise2.2210,00022,20088,731Jun 17 05:39 PM
Farquhar John C.M.Chief Executive OfficerJun 10 '26Sale28.5022,562643,017496,835Jun 12 06:55 PM
Farquhar John C.M.OfficerJun 10 '26Proposed Sale28.5022,562643,017Jun 10 10:47 AM
Rogers CampbellChief Medical OfficerMay 18 '26Option Exercise19.009,219175,16187,950May 20 05:55 PM
Rogers CampbellChief Medical OfficerMay 18 '26Sale28.349,219261,26678,731May 20 05:55 PM
Rogers CampbellOfficerMay 18 '26Proposed Sale28.349,219261,266May 18 11:48 AM
Farquhar John C.M.Chief Executive OfficerMay 11 '26Sale29.1222,562657,005519,397May 13 06:23 PM
Farquhar John C.M.OfficerMay 11 '26Proposed Sale29.1222,562657,005May 11 10:20 AM
Bain Capital Life Sciences Inv10% OwnerApr 30 '26Sale29.23948,75727,733,6448,448,158Apr 30 08:46 PM
Bain Capital Life Sciences Inv10% OwnerApr 29 '26Sale29.37797,13323,411,7969,396,915Apr 30 08:46 PM
Bain Capital Life Sciences Inv10% OwnerApr 28 '26Sale30.51254,1107,752,89610,194,048Apr 30 08:46 PM
Farquhar John C.M.Chief Executive OfficerApr 10 '26Sale26.7222,562602,857549,163Apr 14 05:53 PM
Farquhar John C.M.OfficerApr 10 '26Proposed Sale26.7222,562602,857Apr 10 11:03 AM
Rogers CampbellChief Medical OfficerApr 01 '26Option Exercise2.2567,017150,556145,535Apr 03 06:15 PM
Rogers CampbellChief Medical OfficerApr 01 '26Sale24.6464,5331,590,09381,002Apr 03 06:15 PM
Rogers CampbellOfficerApr 01 '26Proposed Sale24.6464,5331,589,935Apr 01 04:23 PM
Rogers CampbellChief Medical OfficerMar 19 '26Option Exercise2.2267,017148,778143,051Mar 23 06:33 PM
Rogers CampbellChief Medical OfficerMar 19 '26Sale25.6964,5331,658,03378,518Mar 23 06:33 PM
Farquhar John C.M.Chief Executive OfficerMar 18 '26Sale25.009,725243,125571,725Mar 20 06:24 PM
Rogers CampbellOfficerMar 19 '26Proposed Sale25.6964,5331,658,030Mar 19 04:23 PM
Farquhar John C.M.OfficerMar 18 '26Proposed Sale25.009,725243,125Mar 18 02:17 PM
BARABE TIMOTHY CDirectorMar 11 '26Option Exercise2.228,66719,241179,521Mar 12 07:57 PM
Farquhar John C.M.Chief Executive OfficerMar 10 '26Sale22.6612,837290,886581,450Mar 12 07:55 PM
Farquhar John C.M.OfficerMar 10 '26Proposed Sale22.6612,837290,886Mar 10 10:53 AM
Cullivan Julie ADirectorMar 05 '26Sale25.009,122228,05027,291Mar 06 08:18 PM
Cullivan Julie ADirectorMar 05 '26Proposed Sale25.009,122228,050Mar 05 02:11 PM
BARABE TIMOTHY CDirectorFeb 17 '26Option Exercise8.332,49720,800170,854Feb 19 07:14 PM
Rogers CampbellChief Medical OfficerFeb 12 '26Option Exercise5.8467,016391,398141,187Feb 17 08:07 PM
Rogers CampbellChief Medical OfficerFeb 12 '26Sale24.4965,1531,595,48676,034Feb 17 08:07 PM
Rogers CampbellOfficerFeb 12 '26Proposed Sale24.4965,1531,595,485Feb 12 04:45 PM
Farquhar John C.M.Chief Executive OfficerFeb 10 '26Sale27.4622,562619,553591,656Feb 10 08:24 PM
Farquhar John C.M.OfficerFeb 10 '26Proposed Sale27.4622,562619,557Feb 10 04:12 PM
Cullivan Julie ADirectorFeb 05 '26Sale27.328,000218,56036,413Feb 06 09:42 PM
Bain Capital Life Sciences Inv10% OwnerFeb 04 '26Sale28.052,000,00056,100,00010,448,158Feb 06 04:58 PM
Cullivan Julie ADirectorFeb 05 '26Proposed Sale27.328,000218,560Feb 05 09:58 AM
Lightcap Jeffrey CDirectorDec 16 '25Buy26.3440,0001,053,68040,000Dec 17 06:43 PM